298 related articles for article (PubMed ID: 19295457)
1. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
[No Abstract] [Full Text] [Related]
2. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate.
Yalaz M; Akisu M; Hilmioglu S; Calkavur S; Cakmak B; Kultursay N
Mycoses; 2006 May; 49(3):242-5. PubMed ID: 16681818
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin for refractory candidemia in neonates.
Manzar S; Kamat M; Pyati S
Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
[No Abstract] [Full Text] [Related]
5. Experience with caspofungin in the treatment of persistent fungemia in neonates.
Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
[TBL] [Abstract][Full Text] [Related]
6. Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.
Al-Sweih N; Ahmad S; Joseph L; Khan S; Vayalil S; Chandy R; Khan Z
J Clin Microbiol; 2015 Mar; 53(3):1038-41. PubMed ID: 25568433
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis associated with micafungin use in a preterm infant.
King KY; Edwards MS; Word BM
J Perinatol; 2009 Apr; 29(4):320-2. PubMed ID: 19325554
[TBL] [Abstract][Full Text] [Related]
8. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
[TBL] [Abstract][Full Text] [Related]
9. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
10. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.
Natarajan G; Lulic-Botica M; Aranda JV
J Perinatol; 2009 Nov; 29(11):738-43. PubMed ID: 19776753
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.
Olver WJ; Scott F; Shankland GS
Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561
[TBL] [Abstract][Full Text] [Related]
12. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
[TBL] [Abstract][Full Text] [Related]
13. Persistent Candida conglobata bloodstream infection in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.
Al-Sweih N; Ahmad S; Khan S; Khan Z; Joseph L; Vayalil S; Chandy R
J Mycol Med; 2017 Jun; 27(2):271-276. PubMed ID: 28189376
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
McGee WT; Tereso GJ
Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
[TBL] [Abstract][Full Text] [Related]
18. Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight.
Li MJ; Hsueh PR; Lu CY; Chou HC; Lee PI; Chang LY; Huang LM
J Formos Med Assoc; 2012 Jan; 111(1):46-50. PubMed ID: 22333013
[TBL] [Abstract][Full Text] [Related]
19. Echinocandins--an advance in the primary treatment of invasive candidiasis.
Walsh TJ
N Engl J Med; 2002 Dec; 347(25):2070-2. PubMed ID: 12490691
[No Abstract] [Full Text] [Related]
20. A randomized, double-blind, prospective study of caspofungin vs. amphotericin B for the treatment of invasive candidiasis in newborn infants.
Mohamed WA; Ismail M
J Trop Pediatr; 2012 Feb; 58(1):25-30. PubMed ID: 21355042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
